Annual report pursuant to Section 13 and 15(d)

Statements of Operations

v3.3.1.900
Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Operating costs and expenses    
Research and development $ 2,260,297 $ 113,931
Patent costs 243,463 197,731
General and administrative 6,404,643 1,969,960
Total operating costs and expenses 8,908,403 2,281,622
Operating loss (8,908,403) (2,281,622)
Other income (expense)    
Interest income $ 40,876 525
Interest expense (213,516)
Other income $ 79,756 21,148
Other income (expense), net 120,632 (191,843)
Net loss (8,787,771) (2,473,465)
Cumulative preferred stock dividends (327,569) (589,462)
Accretion of discount of Series C preferred stock (63,283) (8,580)
Net loss attributable to common stockholders $ (9,178,623) $ (3,071,507)
Net loss attributable to common stockholders per share, basic and diluted $ (3.11) $ (6.79)
Weighted average shares outstanding, basic and diluted 2,946,792 452,509